Alec Machiels Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Alec Machiels is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 370,761 shares of APLS, which is worth approximately $12.1 Million. The most recent transaction as insider was on Jan 01, 2024, when has been sold 3,341 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K

0% 3M change

0.91% 12M change

Total Value Held $12.1 Million

Alec Machiels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2024	BUY Grant, award, or other acquisition	-	3,341 Added 0.89%	370,761 Common Stock
Nov 17 2023	SELL Open market or private sale	$59,675 $47.74 p/Share	1,250 Reduced 0.34%	367,420 Common Stock
Nov 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.34%	368,670 Common Stock
Oct 17 2023	SELL Open market or private sale	$60,625 $48.5 p/Share	1,250 Reduced 0.34%	367,420 Common Stock
Oct 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.34%	368,670 Common Stock
Sep 18 2023	SELL Open market or private sale	$56,250 $45.0 p/Share	1,250 Reduced 0.34%	367,420 Common Stock
Sep 18 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.34%	368,670 Common Stock
Sep 15 2023	SELL Open market or private sale	$56,675 $45.34 p/Share	1,250 Reduced 0.34%	367,420 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.34%	368,670 Common Stock
Jul 21 2023	BUY Exercise of conversion of derivative security	$132,909 $2.67 p/Share	49,779 Added 11.93%	367,420 Common Stock
Jul 20 2023	BUY Exercise of conversion of derivative security	$133,500 $2.67 p/Share	50,000 Added 13.6%	317,641 Common Stock
Jul 17 2023	SELL Open market or private sale	$80,987 $64.79 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
Jun 20 2023	SELL Open market or private sale	$110,512 $88.41 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Jun 20 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
May 17 2023	SELL Open market or private sale	$110,825 $88.66 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
May 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
Apr 17 2023	SELL Open market or private sale	$101,312 $81.05 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
Mar 17 2023	SELL Open market or private sale	$80,037 $64.03 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Mar 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
Feb 17 2023	SELL Open market or private sale	$65,475 $52.38 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock
Jan 17 2023	SELL Open market or private sale	$65,525 $52.42 p/Share	1,250 Reduced 0.46%	267,641 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.46%	268,891 Common Stock

Alec Machiels

Director

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account